Vontier (VNT) Competitors $38.14 -1.29 (-3.27%) (As of 12/17/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends VNT vs. TER, AVTR, RVTY, BIO.B, NVMI, ST, MIR, TRNS, CTKB, and LABShould you be buying Vontier stock or one of its competitors? The main competitors of Vontier include Teradyne (TER), Avantor (AVTR), Revvity (RVTY), Bio-Rad Laboratories (BIO.B), Nova (NVMI), Sensata Technologies (ST), Mirion Technologies (MIR), Transcat (TRNS), Cytek Biosciences (CTKB), and Standard BioTools (LAB). These companies are all part of the "measuring and control equipment" industry. Vontier vs. Teradyne Avantor Revvity Bio-Rad Laboratories Nova Sensata Technologies Mirion Technologies Transcat Cytek Biosciences Standard BioTools Teradyne (NASDAQ:TER) and Vontier (NYSE:VNT) are both computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, community ranking, analyst recommendations, institutional ownership, media sentiment, risk and valuation. Does the media favor TER or VNT? In the previous week, Teradyne had 8 more articles in the media than Vontier. MarketBeat recorded 21 mentions for Teradyne and 13 mentions for Vontier. Teradyne's average media sentiment score of 1.09 beat Vontier's score of 0.78 indicating that Teradyne is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teradyne 11 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Vontier 5 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals believe in TER or VNT? 99.8% of Teradyne shares are owned by institutional investors. Comparatively, 95.8% of Vontier shares are owned by institutional investors. 0.4% of Teradyne shares are owned by company insiders. Comparatively, 0.8% of Vontier shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has better earnings and valuation, TER or VNT? Teradyne has higher earnings, but lower revenue than Vontier. Vontier is trading at a lower price-to-earnings ratio than Teradyne, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTeradyne$2.68B7.79$448.75M$3.1540.64Vontier$2.99B1.92$376.90M$2.6114.61 Which has more volatility and risk, TER or VNT? Teradyne has a beta of 1.51, indicating that its share price is 51% more volatile than the S&P 500. Comparatively, Vontier has a beta of 1.24, indicating that its share price is 24% more volatile than the S&P 500. Do analysts recommend TER or VNT? Teradyne presently has a consensus price target of $147.25, suggesting a potential upside of 15.03%. Vontier has a consensus price target of $44.44, suggesting a potential upside of 16.53%. Given Vontier's higher probable upside, analysts clearly believe Vontier is more favorable than Teradyne.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Teradyne 0 Sell rating(s) 4 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.69Vontier 0 Sell rating(s) 3 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.67 Does the MarketBeat Community prefer TER or VNT? Teradyne received 28 more outperform votes than Vontier when rated by MarketBeat users. However, 50.62% of users gave Vontier an outperform vote while only 44.23% of users gave Teradyne an outperform vote. CompanyUnderperformOutperformTeradyneOutperform Votes6944.23% Underperform Votes8755.77% VontierOutperform Votes4150.62% Underperform Votes4049.38% Is TER or VNT more profitable? Teradyne has a net margin of 18.75% compared to Vontier's net margin of 13.54%. Vontier's return on equity of 45.48% beat Teradyne's return on equity.Company Net Margins Return on Equity Return on Assets Teradyne18.75% 18.56% 13.91% Vontier 13.54%45.48%10.49% Is TER or VNT a better dividend stock? Teradyne pays an annual dividend of $0.48 per share and has a dividend yield of 0.4%. Vontier pays an annual dividend of $0.10 per share and has a dividend yield of 0.3%. Teradyne pays out 15.2% of its earnings in the form of a dividend. Vontier pays out 3.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. SummaryTeradyne beats Vontier on 14 of the 20 factors compared between the two stocks. Ad Crypto 101 MediaAI Crypto Tool Could Send One Coin SOARING…The #1 AI Coin to Buy Rapid growth predicted for little-known AI crypto projectDiscover our #1 crypto pick before it's too late. Get Vontier News Delivered to You Automatically Sign up to receive the latest news and ratings for VNT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VNT vs. The Competition Export to ExcelMetricVontierFluid meters & counting devices IndustryBusiness SectorNYSE ExchangeMarket Cap$5.73B$6.20B$6.96B$19.63BDividend Yield0.25%0.42%2.90%3.51%P/E Ratio14.6135.6446.0943.82Price / Sales1.925.11449.9117.46Price / Cash10.5334.1629.7221.73Price / Book6.589.745.755.46Net Income$376.90M$234.75M$124.96M$987.18M7 Day Performance-2.63%-2.93%2.35%-2.12%1 Month Performance0.16%2.82%9.56%1.31%1 Year Performance9.22%28.96%32.49%16.44% Vontier Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VNTVontier3.3393 of 5 stars$38.14-3.3%$44.44+16.5%+9.2%$5.73B$2.99B14.618,000TERTeradyne4.9092 of 5 stars$129.55+5.1%$147.25+13.7%+21.7%$21.10B$2.68B39.126,500Analyst UpgradeAVTRAvantor4.9487 of 5 stars$22.35+0.1%$27.69+23.9%-4.5%$15.21B$6.97B48.5414,500RVTYRevvity3.9594 of 5 stars$115.22-0.6%$132.47+15.0%+13.4%$14.02B$2.72B56.0111,500Positive NewsBIO.BBio-Rad LaboratoriesN/A$337.08flatN/A+11.1%$9.44B$2.67B-12.338,200NVMINova3.2225 of 5 stars$191.05+1.4%$227.80+19.2%+49.3%$5.55B$611.85M35.423,606Positive NewsSTSensata Technologies4.664 of 5 stars$30.19-0.6%$41.00+35.8%-18.2%$4.52B$4.05B-56.2419,400MIRMirion Technologies2.534 of 5 stars$18.74+3.9%$18.33-2.2%+79.4%$4.35B$836.90M-54.323,000Positive NewsTRNSTranscat2.9645 of 5 stars$110.15+0.9%$130.25+18.2%+7.7%$1.01B$270.61M54.911,104CTKBCytek Biosciences2.7217 of 5 stars$6.43+3.5%$9.25+43.9%-29.2%$828.26M$201.21M-77.63500Positive NewsLABStandard BioTools3.2118 of 5 stars$2.12+11.0%$2.88+35.6%+11.1%$789.19M$155.90M-2.99620 Related Companies and Tools Related Companies Teradyne Competitors Avantor Competitors Revvity Competitors Bio-Rad Laboratories Competitors Nova Competitors Sensata Technologies Competitors Mirion Technologies Competitors Transcat Competitors Cytek Biosciences Competitors Standard BioTools Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:VNT) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vontier Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vontier With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.